# Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

> **NCT05468502** · PHASE1 · COMPLETED · sponsor: **Shanghai Life Science & Technology** · enrollment: 17 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Human umbilical cord mesenchymal stem cell injection

## Key facts

- **NCT ID:** NCT05468502
- **Lead sponsor:** Shanghai Life Science & Technology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-10
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05468502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05468502, "Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05468502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*